N-(2-((4-cyanophenyl)((1-methyl-1H-imidazol-5-yl)methyl)amino)ethyl)-N-((1,5-dimethyl-1H-pyrazol-4-yl)methyl)-1-methyl-1H-imidazole-4-sulfonamide

ID: ALA1258000

Chembl Id: CHEMBL1258000

PubChem CID: 52940843

Max Phase: Preclinical

Molecular Formula: C24H29N9O2S

Molecular Weight: 507.62

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cc1c(CN(CCN(Cc2cncn2C)c2ccc(C#N)cc2)S(=O)(=O)c2cn(C)cn2)cnn1C

Standard InChI:  InChI=1S/C24H29N9O2S/c1-19-21(12-28-31(19)4)14-33(36(34,35)24-16-29(2)18-27-24)10-9-32(15-23-13-26-17-30(23)3)22-7-5-20(11-25)6-8-22/h5-8,12-13,16-18H,9-10,14-15H2,1-4H3

Standard InChI Key:  KEGHPGKHVUQAID-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA1258000

   N-[2-[4-cyano-N-[(3-methylimidazol-4-yl)methyl]anilino]ethyl]-N-[(1,5-dimethylpyrazol-4-yl)methyl]-1-methylimidazole-4-sulfonamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 507.62

Molecular Weight (Monoisotopic): 507.2165

AlogP: 1.96

#Rotatable Bonds: 10

Polar Surface Area: 117.87

Molecular Species: NEUTRAL

HBA: 10

HBD: ┄

#RO5 Violations: 1

HBA (Lipinski): 11

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): 2

CX Acidic pKa: ┄

CX Basic pKa: 6.22

CX LogP: 1.59

CX LogD: 1.57

Aromatic Rings: 4

Heavy Atoms: 36

QED Weighted: 0.32

Np Likeness Score: -1.64

References

1. Fletcher S, Keaney EP, Cummings CG, Blaskovich MA, Hast MA, Glenn MP, Chang SY, Bucher CJ, Floyd RJ, Katt WP, Gelb MH, Van Voorhis WC, Beese LS, Sebti SM, Hamilton AD..  (2010)  Structure-based design and synthesis of potent, ethylenediamine-based, mammalian farnesyltransferase inhibitors as anticancer agents.,  53  (19): [PMID:20822181] [10.1021/jm1001748]

Source

Source(1):

• Scientific Literature